Please Wait...

BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation

Bolsters Adoption of Compass Intelligent Monitoring Solution

May 21, 2015

BioClinica®, Inc., a leading specialty clinical trials services and technology provider, today announced it has partnered with Kinapse to accelerate Risk-Based Monitoring (RBM) implementation on global clinical trials using BioClinica's Compass Intelligent Monitoring solution.

"Implementing a comprehensive RBM solution can make a real difference in clinical research," BioClinica CEO John Hubbard said. "We're excited about this collaboration as it helps move the industry forward with intelligent monitoring by bringing together our technology and subject matter expertise with Kinapse's broad implementation experience."

Kinapse employs 450 professionals globally and has more than ten years of experience providing strategy and operations consultancy and capability-building programs, including RBM, to life sciences companies.

"In evaluating RBM-enabling technologies, we found BioClinica's Compass provides one of the most comprehensive solutions," said Stuart Donald, vice president of advisory services of Kinapse. "Compass is uniquely designed for RBM and has a rich tool set to solve risk and quality issues, making it the right technology in this new era of monitoring."

Kinapse's role includes easing the change management process as organizations transition to RBM. "We manage implementation from start to finish, including development of supporting processes," Donald said.

The partnership comes at a time of increasing demand for Compass and as several pilot studies using the technology show significant improvement in quality and risk reduction. BioClinica's Vice President of Clinical Innovation, Courtney McBean explained, "Compass catches issues that often go overlooked by onsite monitoring until later in the trial. Finding and fixing issues sooner is less costly and less risky than dealing with bigger problems down the road, especially when it comes to quality and safety."

BioClinica and Kinapse will make a joint presentation, Essential Steps to Successful Risk-Based Monitoring, on June 4 in Tokyo, Japan.

To learn more about BioClinica's Compass, contact Courtney McBean by emailing  Courtney.McBean[a]BioClinica.com or calling (952) 905-8810. Follow BioClinica on the Trial Blazers blog at http://www.bioclinica.com/blog, and on Twitter at http://twitter.com/bioclinica.

About Kinapse
Kinapse provides expert advisory and outsourcing services to life sciences organizations, suppliers and regulators. Kinapse clients include many of the world's leading pharmaceutical, biotechnology, medical device and specialty pharmaceutical companies, government organizations and life sciences service providers. Kinapse has a network of global locations in Europe, the U.S., and Asia Pacific. To learn more about Kinapse, visit www.kinapse.com.

About Bioclinica

Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval.  The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, patient recruitment services, and post-approval research expertise to provide committed, detail-focused service through all stages of drug development.  The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.

Learn more about Bioclinica and our Clinical Adjudication and other offerings at www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Greetings from @DrugInfoAssn's DIA China from team @bioclinica : Haibing Xie; Shuang Zhou; Pencheng Ha; Angel Y.; M… https://t.co/m7cDDYEl5U
bioclinica (Yesterday)
Greetings from Beijing where David Kiger discussed the value of #AI in medical imaging along w optimization of EDC/… https://t.co/AJWNmaivpm
bioclinica (Yesterday)
We're hiring recent tech grads in #RTP for #pharma sector! Our innov. clinical financial solution gives our client… https://t.co/GHgOfszO0T
bioclinica (2 days ago)
Great to be @DrugInfoAssn DIA China! Ask us @bioclinica how sponsors & CROs can optimize electronic data capture… https://t.co/TtE4AiLnqY
bioclinica (2 days ago)
RT @bioclinica: Kinks in the clinical supply chain? Check out how one of our clients is using clinical supply optimization technology for m…
bioclinica (2 days ago)
RT @bioclinica: Welcoming everyone to KOP for #OCTEast Coast!!
bioclinica (2 days ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen